Arkolith/Insider Trading/PBLS/Form 4

Fitzgerald Edward M

DirectorParabilis Medicines, Inc. (PBLS) · full profile →Form 4 · filed Jun 15, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
3 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 11, 2026Conversion(C)6K——6K
Jun 11, 2026Conversion(C)4K——9K
Jun 11, 2026Conversion(C)5K——15K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 11, 2026Conversion(C)5K——0
Jun 11, 2026Conversion(C)4K——0
Jun 11, 2026Conversion(C)8K——0

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-271344) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML